Catalent Inc., a Somerset-based provider of technologies and solutions for health products, announced Alessandro Maselli has been named its new president and chief operating officer.
Prior to his appointment, Maselli served as senior vice president, global solutions at Catalent.
“Catalent has enjoyed strong organic growth and integrated several strategic acquisitions since becoming a publicly traded company. We have now reached a stage where we can benefit from more executive team bandwidth to permit the necessary focus on both external opportunities and on operational excellence across our broad scope of businesses,” John Chiminski, chair and CEO of Catalent, said.
“Alessandro will focus on the growth of our existing businesses, drive integration across our offerings, and meet customers’ ever-expanding needs for improved drug development and supply, while I will focus on long-term strategic growth, exploring future transformational opportunities as well as building deeper partnerships with investors, customers, suppliers, and other external constituencies.”
Effective immediately, Catalent’s four Business Unit presidents will report to Maselli, it said. Maselli will also be responsible for overseeing the heads of global sales and marketing and global quality and regulatory affairs.
“I am honored to be given this opportunity,” Maselli said. “I am confident that we have everything we need to continue to win as we embark on this new chapter. We are expanding our global network, investing in growth-driving capabilities, and elevating our performance to help customers and patients around the world.”
Maselli joined Catalent in 2010 as director of operations at a plant in Italy. In 2013, he was named general manager of Zydis operations in Swindon, United Kingdom, and in 2015 he became vice president of operations, Europe, for Catalent’s Drug Delivery Solutions business unit.
Before Catalent, he held roles at Alstom, SGS and ABB.
